Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)
Clinical trial NCT04978272 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04978272
- Sponsor
- Grant Dorsey, M.D, Ph.D.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2027-05-05
- Enrollment
- 924
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.